StonvexLoading…
StonvexCore line items from PAYX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-05-31 | Annual 2024 2024-05-31 | Annual 2023 2023-05-31 | Annual 2022 2022-05-31 |
|---|---|---|---|---|
Revenue | $5.41B | $5.13B | $4.91B | $4.55B |
Operating Income | $2.21B | $2.17B | $2.03B | $1.84B |
Net Income | $1.66B | $1.69B | $1.56B | $1.39B |
EPS (Diluted) | $4.58 | $4.67 | $4.30 | $3.84 |
Total Assets | $16.56B | $10.38B | $10.55B | $9.64B |
Total Liabilities | $12.44B | $6.58B | $7.05B | $6.55B |
Cash & Equivalents | $1.63B | $1.47B | $1.22B | $370.00M |
Free Cash Flow OCF − CapEx | $1.71B | $1.74B | $1.56B | $1.46B |
Shares Outstanding | 360.50M | 360.10M | 360.50M | 359.90M |